Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase  2 Randomized Controlled Study

ConclusionJapanese patients with episodic migraine receiving preventive treatment with GMB are significantly more satisfied than those receiving PBO.Trial RegistrationClinicalTrials.gov, NCT02959177 (registered November 7, 2016).Graphical Plain Language Summary
Source: Neurology and Therapy - Category: Neurology Source Type: research